Associated degeneration of ventral tegmental area dopaminergic neurons in the rat nigrostriatal lactacystin model of parkinsonism and their neuroprotection by valproate

por Harrison, Ian F., Anis, Hiba K., Dexter, David T.
Publicado 2016

Pathological histone acetylation in Parkinson’s disease: Neuroprotection and inhibition of microglial activation through SIRT 2 inhibition

por Harrison, Ian F., Smith, Andrew D., Dexter, David T.
Publicado 2018

The histone deacetylase inhibitor nicotinamide exacerbates neurodegeneration in the lactacystin rat model of Parkinson's disease

por Harrison, Ian F., Powell, Nicholas M., Dexter, David T.
Publicado 2018

Iron, Neuroinflammation and Neurodegeneration

por Ward, Roberta J., Dexter, David T., Crichton, Robert R.
Publicado 2022

Neuroprotective role for RORA in Parkinson’s disease revealed by analysis of post-mortem brain and a dopaminergic cell line

por Al-Zaid, Felwah S., Hurley, Michael J., Dexter, David T., Gillies, Glenda E.
Publicado 2023

Is Chelation Therapy a Potential Treatment for Parkinson’s Disease?

por Ward, Roberta J., Dexter, David T., Martin-Bastida, Antonio, Crichton, Robert R.
Publicado 2021

Glitazone Treatment and Incidence of Parkinson’s Disease among People with Diabetes: A Retrospective Cohort Study

por Brauer, Ruth, Bhaskaran, Krishnan, Chaturvedi, Nishi, Dexter, David T., Smeeth, Liam, Douglas, Ian
Publicado 2015

Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition

por Croisier, Emilie, Moran, Linda B, Dexter, David T, Pearce, Ronald KB, Graeber, Manuel B
Publicado 2005

Correction: Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition

por Croisier, Emilie, Moran, Linda B, Dexter, David T, Pearce, Ronald KB, Graeber, Manuel B
Publicado 2006

IMPENDING CARDIAC TAMPONADE AS THE INITIAL MANIFESTATION OF BCR-ABL-POSITIVE CML

por Gaballa, Salem, Hlaing, Kyaw, Moursy, Safa, Ahmed, Ameenjamal, Patel, Brijesh, Rallis, Austin, Dexter, David
Publicado 2020

Pivotal Study Evaluating the Safety and Effectiveness of the Abre Venous Self-Expanding Stent System in Patients With Symptomatic Iliofemoral Venous Outflow Obstruction

por Murphy, Erin, Gibson, Kathleen, Sapoval, Marc, Dexter, David J., Kolluri, Raghu, Razavi, Mahmood, Black, Stephen
Publicado 2022

Neuroprotection and Functional Recovery Associated with Decreased Microglial Activation Following Selective Activation of mGluR2/3 Receptors in a Rodent Model of Parkinson's Diseas...

por Chan, Hugh, Paur, Helen, Vernon, Anthony C., Zabarsky, Virginia, Datla, Krishna P., Croucher, Martin J., Dexter, David T.
Publicado 2010

A novel approach to high-grade carotid stenosis with concomitant extracranial carotid aneurysms using transcarotid artery revascularization

por Corbin, Michael A., Alie-Cusson, Fanny S., Dexter, David J., Rathore, Animesh, Shah, Rasesh M., Panneton, Jean M.
Publicado 2021

Inflammatory Pathways in Parkinson's Disease; A BNE Microarray Study

por Durrenberger, Pascal. F., Grünblatt, Edna, Fernando, Francesca S., Monoranu, Camelia Maria, Evans, Jordan, Riederer, Peter, Reynolds, Richard, Dexter, David T.
Publicado 2012

Mean Expression of the X-Chromosome is Associated with Neuronal Density

por Swingland, James T., Durrenberger, Pascal F., Reynolds, Richard, Dexter, David T., Pombo, Ana, Deprez, Manuel, Roncaroli, Federico, Turkheimer, Federico E.
Publicado 2012

Pharmacogenetic stimulation of cholinergic pedunculopontine neurons reverses motor deficits in a rat model of Parkinson’s disease

por Pienaar, Ilse S., Gartside, Sarah E., Sharma, Puneet, De Paola, Vincenzo, Gretenkord, Sabine, Withers, Dominic, Elson, Joanna L., Dexter, David T.
Publicado 2015

The S100A4 Protein Signals through the ErbB4 Receptor to Promote Neuronal Survival

por Pankratova, Stanislava, Klingelhofer, Jorg, Dmytriyeva, Oksana, Owczarek, Sylwia, Renziehausen, Alexander, Syed, Nelofer, Porter, Alexandra E., Dexter, David T., Kiryushko, Darya
Publicado 2018

DREADD Activation of Pedunculopontine Cholinergic Neurons Reverses Motor Deficits and Restores Striatal Dopamine Signaling in Parkinsonian Rats

por Sharma, Puneet K., Wells, Lisa, Rizzo, Gaia, Elson, Joanna L., Passchier, Jan, Rabiner, Eugenii A., Gunn, Roger N., Dexter, David T., Pienaar, Ilse S.
Publicado 2020

BrainNet Europe’s Code of Conduct for brain banking

por Klioueva, Natasja M., Rademaker, Marleen C., Dexter, David T., Al-Sarraj, Safa, Seilhean, Danielle, Streichenberger, Nathalie, Schmitz, Peer, Bell, Jeanne E., Ironside, James W., Arzberger, Thomas, Huitinga, Inge
Publicado 2015

Brain iron chelation by deferiprone in a phase 2 randomised double-blinded placebo controlled clinical trial in Parkinson’s disease

por Martin-Bastida, Antonio, Ward, Roberta J., Newbould, Rexford, Piccini, Paola, Sharp, David, Kabba, Christina, Patel, Maneesh C., Spino, Michael, Connelly, John, Tricta, Fernando, Crichton, Robert R., Dexter, David T.
Publicado 2017